Rekah Pharmaceutical Industry Ltd. (TLV:REKA)
Israel · Delayed Price · Currency is ILS · Price in ILA 1,238.00
+7.00 (0.57%)
Feb 19, 2026, 10:45 AM IDT
TLV:REKA Cash Flow Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -14.11 | 6.21 | -6.91 | -2.04 | 6.62 | 10.8 |
Depreciation & Amortization | 31.06 | 32.52 | 29.84 | 27.48 | 22.86 | 19.71 |
Other Amortization | 0.14 | 0.14 | 0.08 | - | - | - |
Loss (Gain) From Sale of Assets | 0.21 | -23.44 | 0.05 | -0 | -0.05 | -0.03 |
Loss (Gain) From Sale of Investments | -0.44 | -0.23 | 0.04 | -0.04 | -1.19 | - |
Loss (Gain) on Equity Investments | 0.08 | -0.01 | 0.22 | - | 0.13 | 0.64 |
Stock-Based Compensation | 0.01 | -0.14 | 0.19 | 0.4 | 0.45 | 0.1 |
Other Operating Activities | 1.64 | -3.53 | 0.2 | 5.31 | 0.21 | 0.43 |
Change in Accounts Receivable | 27.34 | -8.51 | 6.8 | -14.56 | -14.4 | -10.2 |
Change in Inventory | -9.72 | 14.12 | 2.91 | -2.59 | 13.19 | -28.66 |
Change in Accounts Payable | -20.85 | 5.98 | -2.19 | 26.81 | -3.83 | 14.7 |
Change in Income Taxes | 2.49 | 3.48 | -0.09 | -2.19 | -1.35 | 0.87 |
Change in Other Net Operating Assets | 3.15 | -0.05 | -2.77 | 0.42 | -1.47 | 2.94 |
Operating Cash Flow | 21.01 | 26.54 | 28.35 | 39 | 21.17 | 11.28 |
Operating Cash Flow Growth | -11.05% | -6.38% | -27.31% | 84.24% | 87.62% | -66.73% |
Capital Expenditures | -6.4 | -8.69 | -11.49 | -6.93 | -13.49 | -18.63 |
Sale of Property, Plant & Equipment | 0.39 | 30 | 0.06 | 0.03 | 0.13 | 0.09 |
Cash Acquisitions | - | - | -9.79 | -6 | -25.34 | - |
Sale (Purchase) of Intangibles | -0.01 | -0.01 | -0.32 | -0.55 | -0.51 | -0.21 |
Investment in Securities | 0.45 | 0.15 | 0.04 | - | 3.65 | - |
Other Investing Activities | - | -6.16 | - | - | -0.35 | - |
Investing Cash Flow | -5.57 | 15.29 | -21.5 | -13.45 | -35.9 | -18.74 |
Short-Term Debt Issued | - | 11.35 | 3 | - | - | 5 |
Long-Term Debt Issued | - | 3 | 38 | 10 | 40 | 40 |
Total Debt Issued | 19.4 | 14.35 | 41 | 10 | 40 | 45 |
Short-Term Debt Repaid | - | - | - | -0.01 | -4.99 | - |
Long-Term Debt Repaid | - | -66.73 | -35.74 | -24.35 | -37.78 | -25.92 |
Total Debt Repaid | -30.74 | -66.73 | -35.74 | -24.36 | -42.78 | -25.92 |
Net Debt Issued (Repaid) | -11.33 | -52.38 | 5.26 | -14.36 | -2.78 | 19.08 |
Common Dividends Paid | - | - | - | -10 | - | - |
Other Financing Activities | -1.73 | -1.76 | -13.05 | - | - | - |
Financing Cash Flow | -13.07 | -54.13 | -7.78 | -24.36 | -2.78 | 19.08 |
Foreign Exchange Rate Adjustments | -0.02 | 0.03 | 0.03 | 0.41 | -0.78 | -0.3 |
Net Cash Flow | 2.35 | -12.28 | -0.9 | 1.61 | -18.29 | 11.33 |
Free Cash Flow | 14.61 | 17.85 | 16.86 | 32.07 | 7.68 | -7.35 |
Free Cash Flow Growth | 10.28% | 5.86% | -47.42% | 317.44% | - | - |
Free Cash Flow Margin | 4.87% | 5.55% | 5.24% | 10.97% | 2.91% | -2.77% |
Free Cash Flow Per Share | 1.25 | 1.56 | 1.48 | 2.81 | 0.67 | -0.64 |
Cash Interest Paid | 5.96 | 7.25 | 8.55 | 5.69 | 5.74 | 6.42 |
Cash Income Tax Paid | - | 9.4 | 0.99 | 6.1 | 3.77 | 1.33 |
Levered Free Cash Flow | 8.97 | 37.27 | 12.23 | 33.25 | -0.51 | -11.03 |
Unlevered Free Cash Flow | 12.54 | 41.46 | 17.42 | 36.78 | 3.01 | -7.4 |
Change in Working Capital | 2.42 | 15.02 | 4.65 | 7.9 | -7.87 | -20.36 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.